BIOVIE INC. — Form S-1/A
Filed August 14, 2026 · analyzed by the Registration Agent
S-1/A
— Neutral
significance 28/100
What the filing says
BioVie Inc. (Nevada biotech, ~$32M market cap) executed a placement agency agreement with ThinkEquity LLC dated [*], 2026 for an offering of up to [*] shares of Class A common stock, [*] pre-funded warrants exercisable at $0.0001/share, and [*] common warrants at exercise price of $[*]/share, plus placement agent warrants representing 5% of shares and pre-funded warrants sold. Specific share counts, pricing, and closing date are redacted. ThinkEquity receives 6% cash fee plus 1% non-accountable expense allowance plus warrants. Company locked up 90 days; registration statement on Form S-1 (File No. 333-[*]) is effective.
Why this rating
Placement agency agreement is routine for IPO/capital raise. Redacted material terms (share count, price, proceeds) prevent full impact assessment. For $32M company, financing is potentially material, but lack of concrete dollar amount and missing closing details limit scoring. Standard boilerplate terms.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.